Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Remedium Lifecare has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 14th November, 2025 to consider and take on record the Un-Audited Financial Results/statements (Standalone & Consolidated) of the Company for the Second Quarter and half year ended September 30, 2025 and any other business with the permission of the Chair. Further, the company has informed that pursuant to Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the securities of the Company for the Insiders and all the designated persons as defined in the code is closed from 1st October, 2025 and will re-open after 48 hours of declaration of Un-Audited Financial results/statements (Standalone & Consolidated) for the Second Quarter and half year ended September 30, 2025, which have already been informed of the same.

The above information is a part of company’s filings submitted to BSE.